Cargando…

Molecular Diagnosis in 100% of Dystrophinopathies: Are We There Yet?

Detalles Bibliográficos
Autor principal:	Pegoraro, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954464/ https://www.ncbi.nlm.nih.gov/pubmed/33728374 http://dx.doi.org/10.1212/NXG.0000000000000529

Ejemplares similares

Reassessing carrier status for dystrophinopathies
por: Newcomb, Tara M., et al.
Publicado: (2016)

Advances in Dystrophinopathy Diagnosis and Therapy
por: Saad, Fawzy A., et al.
Publicado: (2023)

Are we there yet?
por: McCann, Shaun R.
Publicado: (2022)

Regenerative medicine: are we there yet?
por: Badylak, Stephen, et al.
Publicado: (2017)

Precision Oncology: Are We There Yet?
Publicado: (2017)

Comprehensive analysis for genetic diagnosis of Dystrophinopathies in Japan
por: Okubo, Mariko, et al.
Publicado: (2017)

The COVID‐19 world – Are we there yet?
por: Hamamoto, Yoshiyuki
Publicado: (2021)

Personalized medicine for asthma: Are we there yet?
por: Poon, Audrey H., et al.
Publicado: (2012)

Biomarkers in Alzheimer disease: are we there yet?
por: Generoso, Jaqueline S., et al.
Publicado: (2020)

Value of Information Analysis: Are We There Yet?
por: Tuffaha, Haitham
Publicado: (2020)

Late-Onset Dystrophinopathy
por: Singh, Ranjan K
Publicado: (2021)

MicroRNAs in Dystrophinopathy
por: Lee, Ahyoung, et al.
Publicado: (2022)

Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathies
por: Bello, Luca, et al.
Publicado: (2016)

Capacity building in endometriosis ultrasound: are we there yet?
por: Menakaya, Uche A
Publicado: (2015)

Digital future in perioperative medicine: Are we there yet?
por: Panchagnula, Umakanth, et al.
Publicado: (2019)

Radiofrequency ablation for primary hyperparathyroidism: are we there yet?
por: McManus, Catherine
Publicado: (2023)

Stem Cell–derived Nanovesicles for the Treatment of Pulmonary Hypertension: Are We There Yet?
por: Goncharova, Elena A., et al.
Publicado: (2022)

Combining Protein Expression and Molecular Data Improves Mutation Characterization of Dystrophinopathies
por: Gaina, Gisela, et al.
Publicado: (2021)

Involvement of adiponectin in the pathogenesis of dystrophinopathy
por: Abou-Samra, Michel, et al.
Publicado: (2015)

Long‐read whole‐genome sequencing for the genetic diagnosis of dystrophinopathies
por: Xie, Zhiying, et al.
Publicado: (2020)

Estrogen, estrogen receptors, and hepatocellular carcinoma: Are we there yet?
por: Sukocheva, Olga A
Publicado: (2018)

Abandoned embryos in Brazil: advances in the decisions. Are we there yet?
por: de Souza, Maria do Carmo Borges, et al.
Publicado: (2018)

Are We There Yet? Emerging Milestones in Aortic Dissection Care
por: Svensson, Lars G.
Publicado: (2019)

Are we there yet? Pushing the boundaries of endonasal surgery into the brainstem
por: Cohen-Gadol, Aaron A.
Publicado: (2020)

Drug Therapy for Obstructive Sleep Apnea: Are We There Yet?
por: Schmickl, Christopher N., et al.
Publicado: (2022)

Commentary: Prognostication of uveal melanoma based on molecular diagnosis - Are we there yet?
por: Attiku, Yamini, et al.
Publicado: (2019)

Adherence to statin therapy: it seems we know everything, yet we do nothing
por: Banach, Maciej, et al.
Publicado: (2022)

Defining the Clinical Utility of the Lung Clearance Index. Are We There Yet?
por: Spano, Jacquelyn, et al.
Publicado: (2021)

World AIDS Day 2007: AIDS at 26, are we there yet?
por: Jeang, Kuan-Teh
Publicado: (2007)

Tbx18 and the generation of a biological pacemaker. Are we there yet?
por: Brand, Thomas
Publicado: (2016)

Optimizing RV lead position in RV cardiomyopathy: Are we there yet?
por: Sharma, Apurva, et al.
Publicado: (2019)

Evidence on technology-driven preoperative exercise interventions: are we there yet?
por: Steffens, Daniel, et al.
Publicado: (2020)

Radiomics-based Management of Indeterminate Lung Nodules? Are We There Yet?
por: Peikert, Tobias, et al.
Publicado: (2020)

PHorecasting Heritable Pulmonary Arterial Hypertension: Are We Nearly There Yet?
por: Aldred, Micheala A.
Publicado: (2020)

Artificial intelligence as an adjunct tool for breast oncologists – are we there yet?
por: Schlam, I., et al.
Publicado: (2023)

Long-term Survival after Critical Illness: Are We There Yet?
por: Prabu R, Natesh
Publicado: (2022)

Clinical and Genetic Characterization of Female Dystrophinopathy
por: Lee, Seung Ha, et al.
Publicado: (2015)

Comprehensive genetic characteristics of dystrophinopathies in China
por: Ma, Peipei, et al.
Publicado: (2018)

Efficacy and safety of hydrokinesitherapy in patients with dystrophinopathy
por: Suslov, V. M., et al.
Publicado: (2023)

Comorbidity and the diagnosis of symptomatic-but-as-yet-undiagnosed cancer
por: Renzi, Cristina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8t3frq29tpi7gi6csudb6lp3cd